The dark side of cell fusion

International Journal of Molecular Sciences

Volumn 17, Issue 5, 2016, Pages

  Bastida Ruiz, Daniel ^a   Van Hoesen, Kylie ^a   Cohen, Marie ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Cancer; Cell fusion; Drug resistance; Metastasis; Syncytin

Indexed keywords

BONE MARROW CELL; CANCER CELL; CANCER THERAPY; CELL FUSION; FERTILIZATION; HUMAN; MUSCLE DEVELOPMENT; PLACENTA DEVELOPMENT; TROPHOBLAST; VIRUS ENTRY; BIOLOGICAL MODEL; CANCER STEM CELL; CYTOLOGY; METABOLISM; METASTASIS; TUMOR EMBOLISM;

PLACENTA PROTEIN; SYNCYTIN; VIRUS ENVELOPE PROTEIN;

BONE MARROW CELLS; CELL FUSION; GENE PRODUCTS, ENV; HUMANS; MODELS, BIOLOGICAL; NEOPLASM METASTASIS; NEOPLASTIC CELLS, CIRCULATING; NEOPLASTIC STEM CELLS; PREGNANCY PROTEINS; TROPHOBLASTS;

EID: 85013735928     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms17050638     Document Type: Review

References (159)

1. Yokota, J. Tumor progression and metastasis. Carcinogenesis 2000, 21, 497-503. [CrossRef] [PubMed]
2. Rajagopalan, H.; Nowak, M.A.; Vogelstein, B.; Lengauer, C. The significance of unstable chromosomes in colorectal cancer. Nat. Rev. Cancer 2003, 3, 695-701. [CrossRef] [PubMed]
3. Lu, X.; Kang, Y. Cell fusion as a hidden force in tumor progression. Cancer Res. 2009, 69, 8536-8539. [CrossRef] [PubMed]
4. Seyfried, T.N.; Huysentruyt, L.C. On the origin of cancer metastasis. Crit. Rev. Oncog. 2013, 18, 43-73. [CrossRef] [PubMed]
5. Aguilar, P.S.; Baylies, M.K.; Fleissner, A.; Helming, L.; Inoue, N.; Podbilewicz, B.; Wang, H.; Wong, M. Genetic basis of cell-cell fusion mechanisms. Trends Genet. 2013, 29, 427-437. [CrossRef] [PubMed]
6. Mohr, M.; Zanker, K.S.; Dittmar, T. Cancer (stem) cell differentiation: An inherent or acquired property? Med. Hypotheses 2015, 85, 1012-1018. [CrossRef] [PubMed]
7. Coward, J.; Harding, A. Size does matter: Why polyploid tumor cells are critical drug targets in the war on cancer. Front. Oncol. 2014, 4, 123. [CrossRef] [PubMed]
8. Zhang, S.; Mercado-Uribe, I.; Xing, Z.; Sun, B.; Kuang, J.; Liu, J. Generation of cancer stem-like cells through the formation of polyploid giant cancer cells. Oncogene 2014, 33, 116-128. [CrossRef] [PubMed]
9. Fox, D.T.; Duronio, R.J. Endoreplication and polyploidy: Insights into development and disease. Development 2013, 140, 3-12. [CrossRef] [PubMed]
10. Gentric, G.; Desdouets, C. Polyploidization in liver tissue. Am. J. Pathol. 2014, 184, 322-331. [CrossRef] [PubMed]
11. Davoli, T.; de Lange, T. The causes and consequences of polyploidy in normal development and cancer. Annu. Rev. Cell Dev. Biol. 2011, 27, 585-610. [CrossRef] [PubMed]
12. Storchova, Z.; Pellman, D. From polyploidy to aneuploidy, genome instability and cancer. Nat. Rev. Mol. Cell Biol. 2004, 5, 45-54. [CrossRef] [PubMed]
13. Ganem, N.J.; Storchova, Z.; Pellman, D. Tetraploidy, aneuploidy and cancer. Curr. Opin. Genet. Dev. 2007, 17, 157-162. [CrossRef] [PubMed]
14. Storchova, Z.; Kuffer, C. The consequences of tetraploidy and aneuploidy. J. Cell Sci. 2008, 121, 3859-3866. [CrossRef] [PubMed]
15. Dewhurst, S.M.; McGranahan, N.; Burrell, R.A.; Rowan, A.J.; Gronroos, E.; Endesfelder, D.; Joshi, T.; Mouradov, D.; Gibbs, P.; Ward, R.L.; et al. Tolerance of whole-genome doubling propagates chromosomal instability and accelerates cancer genome evolution. Cancer Discov. 2014, 4, 175-185. [CrossRef] [PubMed]
16. Ganem, N.J.; Pellman, D. Limiting the proliferation of polyploid cells. Cell 2007, 131, 437-440. [CrossRef] [PubMed]
17. McClendon, A.K.; Dean, J.L.; Ertel, A.; Fu, Z.; Rivadeneira, D.B.; Reed, C.A.; Bourgo, R.J.; Witkiewicz, A.; Addya, S.; Mayhew, C.N.; et al. Rb and p53 cooperate to prevent liver tumorigenesis in response to tissue damage. Gastroenterology 2011, 141, 1439-1450. [CrossRef] [PubMed]
18. Martincorena, I.; Campbell, P.J. Somatic mutation in cancer and normal cells. Science 2015, 349, 1483-1489. [CrossRef] [PubMed]
19. Duelli, D.; Lazebnik, Y. Cell fusion: A hidden enemy? Cancer Cell 2003, 3, 445-448. [CrossRef]
20. Wakeling, W.F.; Greetham, J.; Bennett, D.C. Efficient spontaneous fusion between some co-cultured cells, especially murine melanoma cells. Cell Biol. Int. 1994, 18, 207-210. [CrossRef] [PubMed]
21. Fortuna, M.B.; Dewey, M.J.; Furmanski, P. Cell fusion in tumor development and progression: Occurrence of cell fusion in primary methylcholanthrene-induced tumorigenesis. Int. J. Cancer 1989, 44, 731-737. [CrossRef] [PubMed]
22. Miller, F.R.; McInerney, D.; Rogers, C.; Miller, B.E. Spontaneous fusion between metastatic mammary tumor subpopulations. J. Cell. Biochem. 1988, 36, 129-136. [CrossRef] [PubMed]
23. Dittmar, T.; Zanker, K.S. Tissue regeneration in the chronically inflamed tumor environment: Implications for cell fusion driven tumor progression and therapy resistant tumor hybrid cells. Int. J. Mol. Sci. 2015, 16, 30362-30381. [CrossRef] [PubMed]
24. Yan, B.; Wang, J.; Liu, L. Chemotherapy promotes tumour cell hybridization in vivo. Tumour Biol. 2016, 37, 5025-5030. [CrossRef] [PubMed]
25. Clawson, G.A.; Matters, G.L.; Xin, P.; Imamura-Kawasawa, Y.; Du, Z.; Thiboutot, D.M.; Helm, K.F.; Neves, R.I.; Abraham, T. Macrophage-tumor cell fusions from peripheral blood of melanoma patients. PLoS ONE 2015, 10, e0134320.
26. Goldenberg, D.M.; Zagzag, D.; Heselmeyer-Haddad, K.M.; Berroa Garcia, L.Y.; Ried, T.; Loo, M.; Chang, C.H.; Gold, D.V. Horizontal transmission and retention of malignancy, as well as functional human genes, after spontaneous fusion of human glioblastoma and hamster host cells in vivo. Int. J. Cancer 2012, 131, 49-58. [CrossRef] [PubMed]
27. Tlsty, T.D. Stromal cells can contribute oncogenic signals. Semin. Cancer Biol. 2001, 11, 97-104. [CrossRef] [PubMed]
28. Mueller, M.M.; Fusenig, N.E. Friends or foes-Bipolar effects of the tumour stroma in cancer. Nat. Rev. Cancer 2004, 4, 839-849. [CrossRef] [PubMed]
29. Proia, D.A.; Kuperwasser, C. Stroma: Tumor agonist or antagonist. Cell Cycle 2005, 4, 1022-1025. [CrossRef] [PubMed]
30. Joyce, J.A.; Pollard, J.W. Microenvironmental regulation of metastasis. Nat. Rev. Cancer 2009, 9, 239-252. [CrossRef] [PubMed]
31. Chakraborty, A.K.; Sodi, S.; Rachkovsky, M.; Kolesnikova, N.; Platt, J.T.; Bolognia, J.L.; Pawelek, J.M. A spontaneous murine melanoma lung metastasis comprised of host x tumor hybrids. Cancer Res. 2000, 60, 2512-2519. [PubMed]
32. Miller, F.R.; Mohamed, A.N.; McEachern, D. Production of a more aggressive tumor cell variant by spontaneous fusion of two mouse tumor subpopulations. Cancer Res. 1989, 49, 4316-4321. [PubMed]
33. Jacobsen, B.M.; Harrell, J.C.; Jedlicka, P.; Borges, V.F.; Varella-Garcia, M.; Horwitz, K.B. Spontaneous fusion with, and transformation of mouse stroma by, malignant human breast cancer epithelium. Cancer Res. 2006, 66, 8274-8279. [CrossRef] [PubMed]
34. Ogle, B.M.; Cascalho, M.; Platt, J.L. Biological implications of cell fusion. Nat. Rev. Mol. Cell Biol. 2005, 6, 567-575. [CrossRef] [PubMed]
35. Goldenberg, D.M.; Rooney, R.J.; Loo, M.; Liu, D.; Chang, C.H. In-vivo fusion of human cancer and hamster stromal cells permanently transduces and transcribes human DNA. PLoS ONE 2014, 9, e107927. [CrossRef] [PubMed]
36. Powell, A.E.; Anderson, E.C.; Davies, P.S.; Silk, A.D.; Pelz, C.; Impey, S.; Wong, M.H. Fusion between intestinal epithelial cells and macrophages in a cancer context results in nuclear reprogramming. Cancer Res. 2011, 71, 1497-1505. [CrossRef] [PubMed]
37. Cooper, G.M. Tumor suppressor genes. In The Cell: A Molecular Approach, 2nd ed.; Sinauer Associates: Sunderland, MA, USA, 2000.
38. Chaffer, C.L.; Weinberg, R.A. A perspective on cancer cell metastasis. Science 2011, 331, 1559-1564. [CrossRef] [PubMed]
39. Kalluri, R.; Neilson, E.G. Epithelial-mesenchymal transition and its implications for fibrosis. J. Clin. Investig. 2003, 112, 1776-1784. [CrossRef] [PubMed]
40. Qian, B.Z.; Pollard, J.W. Macrophage diversity enhances tumor progression and metastasis. Cell 2010, 141, 39-51. [CrossRef] [PubMed]
41. Hanahan, D.; Coussens, L.M. Accessories to the crime: Functions of cells recruited to the tumor microenvironment. Cancer Cell 2012, 21, 309-322. [CrossRef] [PubMed]
42. Peinado, H.; Rafii, S.; Lyden, D. Inflammation joins the "Niche". Cancer Cell 2008, 14, 347-349. [CrossRef] [PubMed]
43. Pawelek, J.M.; Chakraborty, A.K. Fusion of tumour cells with bone marrow-derived cells: A unifying explanation for metastasis. Nat. Rev. Cancer 2008, 8, 377-386. [CrossRef] [PubMed]
44. Biswas, S.K.; Sica, A.; Lewis, C.E. Plasticity of macrophage function during tumor progression: Regulation by distinct molecular mechanisms. J. Immunol. 2008, 180, 2011-2017. [CrossRef] [PubMed]
45. Pawelek, J.M. Tumour cell hybridization and metastasis revisited. Melanoma Res. 2000, 10, 507-514. [CrossRef] [PubMed]
46. Friedl, P. Prespecification and plasticity: Shifting mechanisms of cell migration. Curr. Opin. Cell Biol. 2004, 16, 14-23. [CrossRef] [PubMed]
47. Kang, Y.; Massague, J. Epithelial-mesenchymal transitions: Twist in development and metastasis. Cell 2004, 118, 277-279. [CrossRef] [PubMed]
48. Thiery, J.P.; Acloque, H.; Huang, R.Y.; Nieto, M.A. Epithelial-mesenchymal transitions in development and disease. Cell 2009, 139, 871-890. [CrossRef] [PubMed]
49. Yang, J.; Mani, S.A.; Donaher, J.L.; Ramaswamy, S.; Itzykson, R.A.; Come, C.; Savagner, P.; Gitelman, I.; Richardson, A.; Weinberg, R.A. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 2004, 117, 927-939. [CrossRef] [PubMed]
50. Fidler, I.J. The pathogenesis of cancer metastasis: The "seed and soil" hypothesis revisited. Nat. Rev. Cancer 2003, 3, 453-458. [CrossRef] [PubMed]
51. Thiery, J.P. Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer 2002, 2, 442-454. [CrossRef] [PubMed]
52. Huysentruyt, L.C.; Seyfried, T.N. Perspectives on the mesenchymal origin of metastatic cancer. Cancer Metastasis Rev. 2010, 29, 695-707. [CrossRef] [PubMed]
53. Chakraborty, A.K.; de Freitas Sousa, J.; Espreafico, E.M.; Pawelek, J.M. Human monocyte x mouse melanoma fusion hybrids express human gene. Gene 2001, 275, 103-106. [CrossRef]
54. Mekler, L.B.; Drize, O.B.; Osechinskii, I.V.; Shliankevich, M.A. Transformation of a normal differentiated cell of an adult organism, induced by the fusion of this cell with another normal cell of the same organism but with different organ or tissue specificity. Vestn. Akad. Med. Nauk. SSSR 1971, 26, 75-80. [PubMed]
55. Warner, T.F. Cell hybridizaiton: An explanation for the phenotypic diversity of certain tumours. Med. Hypotheses 1975, 1, 51-57. [CrossRef]
56. Shabo, I.; Olsson, H.; Sun, X.F.; Svanvik, J. Expression of the macrophage antigen CD163 in rectal cancer cells is associated with early local recurrence and reduced survival time. Int. J. Cancer 2009, 125, 1826-1831. [CrossRef] [PubMed]
57. Shabo, I.; Midtbo, K.; Andersson, H.; Akerlund, E.; Olsson, H.; Wegman, P.; Gunnarsson, C.; Lindstrom, A. Macrophage traits in cancer cells are induced by macrophage-cancer cell fusion and cannot be explained by cellular interaction. BMC Cancer 2015, 15, 922. [PubMed]
58. Chambers, A.F.; Groom, A.C.; MacDonald, I.C. Dissemination and growth of cancer cells in metastatic sites. Nat. Rev. Cancer 2002, 2, 563-572. [CrossRef] [PubMed]
59. Paget, S. The distribution of secondary growths in cancer of the breast. 1889. Cancer Metastasis Rev. 1989, 8, 98-101. [PubMed]
60. Seyfried, T. Cancer as a Metabolic Disease: On the Origin, Management, and Prevention of Cancer, 1st ed.; John Wiley & Sons: Hoboken, NJ, USA, 2012.
61. Hofer, S.O.; Molema, G.; Hermens, R.A.; Wanebo, H.J.; Reichner, J.S.; Hoekstra, H.J. The effect of surgical wounding on tumour development. Eur. J. Surg. Oncol. 1999, 25, 231-243. [CrossRef] [PubMed]
62. De Baetselier, P.; Roos, E.; Brys, L.; Remels, L.; Gobert, M.; Dekegel, D.; Segal, S.; Feldman, M. Nonmetastatic tumor cells acquiremetastatic properties following somatic hybridizationwith normal cells. CancerMetastasis Rev. 1984, 3, 5-24. [CrossRef] [PubMed]
63. Podsypanina, K.; Du, Y.C.; Jechlinger, M.; Beverly, L.J.; Hambardzumyan, D.; Varmus, H. Seeding and propagation of untransformed mouse mammary cells in the lung. Science 2008, 321, 1841-1844. [CrossRef] [PubMed]
64. Levin, T.G.; Powell, A.E.; Davies, P.S.; Silk, A.D.; Dismuke, A.D.; Anderson, E.C.; Swain, J.R.; Wong, M.H. Characterization of the intestinal cancer stem cell marker CD166 in the human and mouse gastrointestinal tract. Gastroenterology 2010, 139, 2072-2082. [CrossRef] [PubMed]
65. Seyfried, T.N.; Kiebish, M.A.; Marsh, J.; Shelton, L.M.; Huysentruyt, L.C.; Mukherjee, P. Metabolic management of brain cancer. Biochim. Biophys. Acta 2011, 1807, 577-594. [CrossRef] [PubMed]
66. Zhang, J.; Lou, X.; Zellmer, L.; Liu, S.; Xu, N.; Liao, D.J. Just like the rest of evolution in mother nature, the evolution of cancers may be driven by natural selection, and not by haphazard mutations. Oncoscience 2014, 1, 580-590. [CrossRef] [PubMed]
67. Nagler, C.; Hardt, C.; Zanker, K.S.; Dittmar, T. Co-cultivation of murine bmdcs with 67NR mouse mammary carcinoma cells give rise to highly drug resistant cells. Cancer Cell Int. 2011, 11, 21. [CrossRef] [PubMed]
68. Lu, X.; Kang, Y. Efficient acquisition of dual metastasis organotropism to bone and lung through stable spontaneous fusion between MDA-MB-231 variants. Proc. Natl. Acad. Sci. USA 2009, 106, 9385-9390. [CrossRef] [PubMed]
69. Clarke, M.F.; Dick, J.E.; Dirks, P.B.; Eaves, C.J.; Jamieson, C.H.; Jones, D.L.; Visvader, J.; Weissman, I.L.; Wahl, G.M. Cancer stem cells-perspectives on current status and future directions: AACR workshop on cancer stem cells. Cancer Res. 2006, 66, 9339-9344. [CrossRef] [PubMed]
70. Bjerkvig, R.; Tysnes, B.B.; Aboody, K.S.; Najbauer, J.; Terzis, A.J. Opinion: The origin of the cancer stem cell: Current controversies and new insights. Nat. Rev. Cancer 2005, 5, 899-904. [CrossRef] [PubMed]
71. Li, F.; Tiede, B.; Massague, J.; Kang, Y. Beyond tumorigenesis: Cancer stem cells in metastasis. Cell Res. 2007, 17, 3-14. [CrossRef] [PubMed]
72. Dittmar, T.; Nagler, C.; Schwitalla, S.; Reith, G.; Niggemann, B.; Zanker, K.S. Recurrence cancer stem cells-Made by cell fusion? Med. Hypotheses 2009, 73, 542-547. [CrossRef] [PubMed]
73. Lu, X.; Kang, Y. Cell fusion hypothesis of cancer stem cells. In Cell Fusion in Health and Disease. Volume ii: Cell Fusion in Disease, 1st ed.; Dittmar, T., Zänker, K.S., Eds.; Springer Netherlands: Dordrecht, The Netherlands, 2011; pp. 129-140.
74. Houghton, J.M. Bone-marrow-derived cells and cancer-An opportunity for improved therapy. Nat. Rev. Clin. Oncol. 2007, 4, 2-3. [CrossRef] [PubMed]
75. Quintana, E.; Shackleton, M.; Sabel, M.S.; Fullen, D.R.; Johnson, T.M.; Morrison, S.J. Efficient tumour formation by single human melanoma cells. Nature 2008, 456, 593-598. [CrossRef] [PubMed]
76. Zhou, B.B.; Zhang, H.; Damelin, M.; Geles, K.G.; Grindley, J.C.; Dirks, P.B. Tumour-initiating cells: Challenges and opportunities for anticancer drug discovery. Nat. Rev. Drug Discov. 2009, 8, 806-823. [CrossRef] [PubMed]
77. Phillips, T.M.; McBride, W.H.; Pajonk, F. The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation. J. Natl. Cancer Inst. 2006, 98, 1777-1785. [CrossRef] [PubMed]
78. Woodward, W.A.; Chen, M.S.; Behbod, F.; Alfaro, M.P.; Buchholz, T.A.; Rosen, J.M. WNT/β-catenin mediates radiation resistance of mouse mammary progenitor cells. Proc. Natl. Acad. Sci. USA 2007, 104, 618-623. [CrossRef] [PubMed]
79. Nagler, C.; Zänker, K.S.; Dittmar, T. Cell fusion, drug resistance and recurrence cscs. In Cell Fusion in Health and Disease. Volume II: Cell Fusion in Disease, 1st ed.; Zänker, K.S., Dittmar, T., Eds.; Springer Netherlands: Dordrecht, The Netherlands, 2011; pp. 173-182.
80. Zhang, D.; Wang, Y.; Zhang, S. Asymmetric cell division in polyploid giant cancer cells and low eukaryotic cells. BioMed Res. Int. 2014, 2014, 432652. [CrossRef] [PubMed]
81. Kawano, N.; Harada, Y.; Yoshida, K.; Miyado, M.; Miyado, K. Role of CD9 in sperm-egg fusion and its general role in fusion phenomena. In Cell Fusions: Regulation and Control, 1st ed.; Larsson, L.-I., Ed.; Springer Netherlands: Dordrecht, The Netherlands, 2010; pp. 171-184.
82. Yi, Y.-J.; Zimmerman, S.W.; Sutovsky, P. Gamete binding and fusion. In Cell Fusions: Regulation and Control, 1st ed.; Larsson, L.-I., Ed.; Springer Netherlands: Dordrecht, The Netherlands, 2010; pp. 185-201.
83. Chen, E.H.; Grote, E.; Mohler, W.; Vignery, A. Cell-cell fusion. FEBS Lett. 2007, 581, 2181-2193. [CrossRef] [PubMed]
84. Horsley, V.; Pavlath, G.K. Forming a multinucleated cell: Molecules that regulate myoblast fusion. Cells Tissues Organs 2004, 176, 67-78. [CrossRef] [PubMed]
85. Buckingham, M. Myogenic progenitor cells and skeletal myogenesis in vertebrates. Curr. Opin. Genet. Dev. 2006, 16, 525-532. [CrossRef] [PubMed]
86. Vignery, A. Osteoclasts and giant cells: Macrophage-macrophage fusion mechanism. Int. J. Exp. Pathol. 2000, 81, 291-304. [CrossRef] [PubMed]
87. Vignery, A. Macrophage fusion: The making of osteoclasts and giant cells. J. Exp. Med. 2005, 202, 337-340. [CrossRef] [PubMed]
88. Kaji, K.; Oda, S.; Miyazaki, S.; Kudo, A. Infertility of CD9-deficient mouse eggs is reversed by mouse CD9, human CD9, or mouse CD81; polyadenylated mrna injection developed for molecular analysis of sperm-egg fusion. Dev. Biol. 2002, 247, 327-334. [CrossRef] [PubMed]
89. Kaji, K.; Oda, S.; Shikano, T.; Ohnuki, T.; Uematsu, Y.; Sakagami, J.; Tada, N.; Miyazaki, S.; Kudo, A. The gamete fusion process is defective in eggs of CD9-deficient mice. Nat. Genet. 2000, 24, 279-282. [CrossRef] [PubMed]
90. Le Naour, F.; Rubinstein, E.; Jasmin, C.; Prenant, M.; Boucheix, C. Severely reduced female fertility in CD9-deficient mice. Science 2000, 287, 319-321. [CrossRef] [PubMed]
91. Miyado, K.; Yamada, G.; Yamada, S.; Hasuwa, H.; Nakamura, Y.; Ryu, F.; Suzuki, K.; Kosai, K.; Inoue, K.; Ogura, A.; et al. Requirement of CD9 on the egg plasma membrane for fertilization. Science 2000, 287, 321-324. [CrossRef] [PubMed]
92. Rubinstein, E.; Ziyyat, A.; Prenant, M.; Wrobel, E.; Wolf, J.P.; Levy, S.; Le Naour, F.; Boucheix, C. Reduced fertility of female mice lacking CD81. Dev. Biol. 2006, 290, 351-358. [CrossRef] [PubMed]
93. Tanigawa, M.; Miyamoto, K.; Kobayashi, S.; Sato, M.; Akutsu, H.; Okabe, M.; Mekada, E.; Sakakibara, K.; Miyado, M.; Umezawa, A.; et al. Possible involvement of CD81 in acrosome reaction of sperm in mice. Mol. Reprod. Dev. 2008, 75, 150-155. [CrossRef] [PubMed]
94. Evans, J.P. Fertilin β and other adams as integrin ligands: Insights into cell adhesion and fertilization. Bioessays 2001, 23, 628-639. [CrossRef] [PubMed]
95. Okabe, M.; Adachi, T.; Takada, K.; Oda, H.; Yagasaki, M.; Kohama, Y.; Mimura, T. Capacitation-related changes in antigen distribution on mouse sperm heads and its relation to fertilization rate in vitro. J. Reprod. Immunol. 1987, 11, 91-100. [CrossRef]
96. Inoue, N.; Ikawa, M.; Isotani, A.; Okabe, M. The immunoglobulin superfamily protein izumo is required for sperm to fuse with eggs. Nature 2005, 434, 234-238. [CrossRef] [PubMed]
97. Önel, S.-F.; Dottermusch, C.; Sickmann, A.; Buttgereit, D.; Renkawitz-Pohl, R. Role of the actin cytoskeleton within furmas during drosophila myoblast fusion and first functionally conserved factors in vertebrates. In Cell Fusions: Regulation and Control, 1st ed.; Larsson, L.-I., Ed.; Springer Netherlands: Dordrecht, The Netherlands, 2010; pp. 139-170.
98. Fischbach, K.F.; Linneweber, G.A.; Andlauer, T.F.; Hertenstein, A.; Bonengel, B.; Chaudhary, K. The IRRE cell recognition module (IRM) proteins. J. Neurogenet. 2009, 23, 48-67. [CrossRef] [PubMed]
99. Uluckan, O.; Becker, S.N.; Deng, H.; Zou, W.; Prior, J.L.; Piwnica-Worms, D.; Frazier, W.A.; Weilbaecher, K.N. CD47 regulates bone mass and tumor metastasis to bone. Cancer Res. 2009, 69, 3196-3204. [CrossRef] [PubMed]
100. Kukreja, A.; Radfar, S.; Sun, B.H.; Insogna, K.; Dhodapkar, M.V. Dominant role of CD47-thrombospondin-1 interactions in myeloma-induced fusion of human dendritic cells: Implications for bone disease. Blood 2009, 114, 3413-3421. [CrossRef] [PubMed]
101. Cui, W.; Ke, J.Z.; Zhang, Q.; Ke, H.Z.; Chalouni, C.; Vignery, A. The intracellular domain of CD44 promotes the fusion of macrophages. Blood 2006, 107, 796-805. [CrossRef] [PubMed]
102. lo precursors are the master fusogens. J. Cell. Physiol. 2010, 223, 76-83. [PubMed]
103. Yagi, M.; Miyamoto, T.; Sawatani, Y.; Iwamoto, K.; Hosogane, N.; Fujita, N.; Morita, K.; Ninomiya, K.; Suzuki, T.; Miyamoto, K.; et al. DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant cells. J. Exp. Med. 2005, 202, 345-351. [CrossRef] [PubMed]
104. Witwicka, H.; Hwang, S.Y.; Reyes-Gutierrez, P.; Jia, H.; Odgren, P.E.; Donahue, L.R.; Birnbaum, M.J.; Odgren, P.R. Studies of OC-STAMP in osteoclast fusion: A new knockout mouse model, rescue of cell fusion, and transmembrane topology. PLoS ONE 2015, 10, e0128275. [CrossRef] [PubMed]
105. Chiu, Y.G.; Ritchlin, C.T. Dc-stamp: A key regulator in osteoclast differentiation. J. Cell. Physiol. 2016. [CrossRef] [PubMed]
106. Pérot, P.; Montgiraud, C.; Lavillette, D.; Mallet, F. A comparative portrait of retroviral fusogens and syncytins. In Cell Fusions: Regulation and Control, 1st ed.; Larsson, L.-I., Ed.; Springer Netherlands: Dordrecht, The Netherlands, 2010; pp. 63-115.
107. Gerbaud, P.; Pidoux, G. Review: An overview of molecular events occurring in human trophoblast fusion. Placenta 2015, 36, S35-S42. [CrossRef] [PubMed]
108. Benirschke, K.; Burton, G.J.; Baergen, R.N. Architecture of normal villous trees. In Pathology of the Human Placenta, 6th ed.; Springer-Verlag: Berlin, Germany; Heidelberg, Germany, 2012; pp. 101-144.
109. Benirschke, K.; Burton, G.J.; Baergen, R.N. Early development of the human placenta. In Pathology of the Human Placenta, 6th ed.; Springer-Verlag: Berlin, Germany; Heidelberg, Germany, 2012; pp. 41-53.
110. Eaton, B.; Contractor, S. In vitro assessment of trophoblast receptors and placental transport mechanisms. In The Human Placenta, 1st ed.; Redman, C.W., Sargent, I.L., Starkey, P.M., Eds.; Blackwell Scientific Publication: London, UK, 1993; pp. 471-503.
111. Ogren, L.; Talamentes, F. The placenta as an endocrine organ: Polypeptides. In The Physiology of Reproduction, 2nd ed.; Knobil, E., Neill, J., Eds.; Raven Press: New York, NY, USA, 1994; pp. 875-945.
112. Bozzuto, G.; Ruggieri, P.; Molinari, A. Molecular aspects of tumor cell migration and invasion. Ann. Ist. Super Sanita. 2010, 46, 66-80. [CrossRef] [PubMed]
113. Blond, J.L.; Beseme, F.; Duret, L.; Bouton, O.; Bedin, F.; Perron, H.; Mandrand, B.; Mallet, F. Molecular characterization and placental expression of HERV-W, a new human endogenous retrovirus family. J. Virol. 1999, 73, 1175-1185. [PubMed]
114. Mi, S.; Lee, X.; Li, X.; Veldman, G.M.; Finnerty, H.; Racie, L.; LaVallie, E.; Tang, X.Y.; Edouard, P.; Howes, S.; et al. Syncytin is a captive retroviral envelope protein involved in human placental morphogenesis. Nature 2000, 403, 785-789. [PubMed]
115. Blaise, S.; de Parseval, N.; Heidmann, T. Functional characterization of two newly identified human endogenous retrovirus coding envelope genes. Retrovirology 2005, 2, 19. [CrossRef] [PubMed]
116. Larsson, L.I.; Bjerregaard, B.; Talts, J.F. Cell fusions in mammals. Histochem. Cell Biol. 2008, 129, 551-561. [CrossRef] [PubMed]
117. Jahn, R.; Lang, T.; Sudhof, T.C. Membrane fusion. Cell 2003, 112, 519-533. [CrossRef]
118. Chen, E.H.; Olson, E.N. Unveiling the mechanisms of cell-cell fusion. Science 2005, 308, 369-373. [CrossRef] [PubMed]
119. Hu, C.; Ahmed, M.; Melia, T.J.; Sollner, T.H.; Mayer, T.; Rothman, J.E. Fusion of cells by flipped snares. Science 2003, 300, 1745-1749. [CrossRef] [PubMed]
120. Caceres, M.; Thomas, J.W. The gene of retroviral origin syncytin 1 is specific to hominoids and is inactive in old world monkeys. J. Hered. 2006, 97, 100-106. [CrossRef] [PubMed]
121. Lander, E.S.; Linton, L.M.; Birren, B.; Nusbaum, C.; Zody, M.C.; Baldwin, J.; Devon, K.; Dewar, K.; Doyle, M.; FitzHugh, W.; et al. Initial sequencing and analysis of the human genome. Nature 2001, 409, 860-921. [CrossRef] [PubMed]
122. Maliniemi, P.; Vincendeau, M.; Mayer, J.; Frank, O.; Hahtola, S.; Karenko, L.; Carlsson, E.; Mallet, F.; Seifarth, W.; Leib-Mosch, C.; et al. Expression of human endogenous retrovirus-w including syncytin-1 in cutaneous t-cell lymphoma. PLoS ONE 2013, 8, e76281. [CrossRef] [PubMed]
123. Yu, H.; Liu, T.; Zhao, Z.; Chen, Y.; Zeng, J.; Liu, S.; Zhu, F. Mutations in 3'-long terminal repeat of HERV-W family in chromosome 7 upregulate syncytin-1 expression in urothelial cell carcinoma of the bladder through interacting with C-MYB. Oncogene 2014, 33, 3947-3958. [CrossRef] [PubMed]
124. Strissel, P.L.; Ruebner, M.; Thiel, F.; Wachter, D.; Ekici, A.B.; Wolf, F.; Thieme, F.; Ruprecht, K.; Beckmann, M.W.; Strick, R. Reactivation of codogenic endogenous retroviral (ERV) envelope genes in human endometrial carcinoma and prestages: Emergence of new molecular targets. Oncotarget. 2012, 3, 1204-1219. [CrossRef] [PubMed]
125. Strick, R.; Ackermann, S.; Langbein, M.; Swiatek, J.; Schubert, S.W.; Hashemolhosseini, S.; Koscheck, T.; Fasching, P.A.; Schild, R.L.; Beckmann, M.W.; et al. Proliferation and cell-cell fusion of endometrial carcinoma are induced by the human endogenous retroviral syncytin-1 and regulated by TGF-β. J. Mol. Med. 2007, 85, 23-38. [CrossRef] [PubMed]
126. Sun, Y.; Ouyang, D.Y.; Pang, W.; Tu, Y.Q.; Li, Y.Y.; Shen, X.M.; Tam, S.C.; Yang, H.Y.; Zheng, Y.T. Expression of syncytin in leukemia and lymphoma cells. Leuk. Res. 2010, 34, 1195-1202. [CrossRef] [PubMed]
127. Yi, J.M.; Kim, H.M.; Kim, H.S. Expression of the human endogenous retrovirus HERV-W family in various human tissues and cancer cells. J. Gen. Virol. 2004, 85, 1203-1210. [CrossRef] [PubMed]
128. Larsen, J.M.; Christensen, I.J.; Nielsen, H.J.; Hansen, U.; Bjerregaard, B.; Talts, J.F.; Larsson, L.I. Syncytin immunoreactivity in colorectal cancer: Potential prognostic impact. Cancer Lett. 2009, 280, 44-49. [CrossRef] [PubMed]
129. Larsson, L.I.; Holck, S.; Christensen, I.J. Prognostic role of syncytin expression in breast cancer. Hum. Pathol. 2007, 38, 726-731. [CrossRef] [PubMed]
130. Bjerregaard, B.; Holck, S.; Christensen, I.J.; Larsson, L.I. Syncytin is involved in breast cancer-endothelial cell fusions. Cell. Mol. Life Sci. 2006, 63, 1906-1911. [CrossRef] [PubMed]
131. Yi, J.M.; Lee, W.H.; Kim, H.M.; Kim, H.S. Identification of new endogenous retroviral sequences belonging to the HERV-W family in human cancer cells. Intervirology 2001, 44, 333-338. [CrossRef] [PubMed]
132. Kudo, Y.; Boyd, C.A. Changes in expression and function of syncytin and its receptor, amino acid transport system B(0) (ASCT2), in human placental choriocarcinoma bewo cells during syncytialization. Placenta 2002, 23, 536-541. [CrossRef] [PubMed]
133. Borges, M.; Bose, P.; Frank, H.G.; Kaufmann, P.; Potgens, A.J. A two-colour fluorescence assay for the measurement of syncytial fusion between trophoblast-derived cell lines. Placenta 2003, 24, 959-964. [CrossRef]
134. Esnault, C.; Priet, S.; Ribet, D.; Vernochet, C.; Bruls, T.; Lavialle, C.; Weissenbach, J.; Heidmann, T. A placenta-specific receptor for the fusogenic, endogenous retrovirus-derived, human syncytin-2. Proc. Natl. Acad. Sci. USA 2008, 105, 17532-17537. [CrossRef] [PubMed]
135. Strick, R.; Beckmann, M.W.; Strissel, P.L. Cell-cell fusions and human endogenous retroviruses in cancer. In Cell Fusions: Regulation and Control, 1st ed.; Larsson, L.-I., Ed.; Springer Netherlands: Dordrecht, The Netherlands, 2010; pp. 395-426.
136. Li, J.; Lee, A.S. Stress induction of GRP78/BIP and its role in cancer. Curr. Mol. Med. 2006, 6, 45-54. [CrossRef] [PubMed]
137. Fradet, S.; Pierredon, S.; Ribaux, P.; Epiney, M.; Shin Ya, K.; Irion, O.; Cohen, M. Involvement of membrane GRP78 in trophoblastic cell fusion. PLoS ONE 2012, 7, e40596. [CrossRef] [PubMed]
138. Cohen, M.; Ribaux, P.; Epiney, M.; Irion, O. Role of prostate apoptosis response 4 in translocation of GRP78 from the endoplasmic reticulum to the cell surface of trophoblastic cells. PLoS ONE 2013, 8, e80231. [CrossRef] [PubMed]
139. Chang, C.; Chen, P.T.; Chang, G.D.; Huang, C.J.; Chen, H. Functional characterization of the placental fusogenic membrane protein syncytin. Biol. Reprod. 2004, 71, 1956-1962. [PubMed]
140. Gong, R.; Peng, X.; Kang, S.; Feng, H.; Huang, J.; Zhang, W.; Lin, D.; Tien, P.; Xiao, G. Structural characterization of the fusion core in syncytin, envelope protein of human endogenous retrovirus family W. Biochem. Biophys. Res. Commun. 2005, 331, 1193-1200. [PubMed]
141. Chernomordik, L.V.; Kozlov, M.M. Mechanics of membrane fusion. Nat. Struct. Mol. Biol. 2008, 15, 675-683. [PubMed]
142. Riddell, M.R.; Winkler-Lowen, B.; Jiang, Y.; Davidge, S.T.; Guilbert, L.J. Pleiotropic actions of forskolin result in phosphatidylserine exposure in primary trophoblasts. PLoS ONE 2013, 8, e81273.
143. Takeda, M.; Leser, G.P.; Russell, C.J.; Lamb, R.A. Influenza virus hemagglutinin concentrates in lipid raft microdomains for efficient viral fusion. Proc. Natl. Acad. Sci. USA 2003, 100, 14610-14617. [PubMed]
144. Suomalainen, M. Lipid rafts and assembly of enveloped viruses. Traffic 2002, 3, 705-709. [CrossRef] [PubMed]
145. Langbein, M.; Strick, R.; Strissel, P.L.; Vogt, N.; Parsch, H.; Beckmann, M.W.; Schild, R.L. Impaired cytotrophoblast cell-cell fusion is associated with reduced syncytin and increased apoptosis in patients with placental dysfunction. Mol. Reprod. Dev. 2008, 75, 175-183. [CrossRef] [PubMed]
146. Chen, C.P.; Wang, K.G.; Chen, C.Y.; Yu, C.; Chuang, H.C.; Chen, H. Altered placental syncytin and its receptor ASCT2 expression in placental development and pre-eclampsia. BJOG 2006, 113, 152-158. [CrossRef] [PubMed]
147. Lee, X.; Keith, J.C., Jr.; Stumm, N.; Moutsatsos, I.; McCoy, J.M.; Crum, C.P.; Genest, D.; Chin, D.; Ehrenfels, C.; Pijnenborg, R.; et al. Downregulation of placental syncytin expression and abnormal protein localization in pre-eclampsia. Placenta 2001, 22, 808-812. [CrossRef] [PubMed]
148. Zhou, Y.; Mohan, A.; Moore, D.C.; Lin, L.; Zhou, F.L.; Cao, J.; Wu, Q.; Qin, Y.X.; Reginato, A.M.; Ehrlich, M.G.; et al. SHP2 regulates osteoclastogenesis by promoting preosteoclast fusion. FASEB J. 2015, 29, 1635-1645. [CrossRef] [PubMed]
149. Skeel, R.T.; Khleif, S. Handbook of Cancer Chemotherapy, 8th ed.; LippincottWilliams andWilkins: Philadelphia, PA, USA, 2011.
150. Gong, J.; Koido, S. Cell fusion and dendritic cell-based vaccines. In Cell Fusions: Regulation and Control, 1st ed.; Larsson, L.-I., Ed.; Springer Netherlands: Dordrecht, The Netherlands, 2010; pp. 315-350.
151. Koido, S.; Hara, E.; Homma, S.; Ohkusa, T.; Gong, J.; Tajiri, H. Cancer immunotherapy by fusions of dendritic cells and tumor cells. Immunotherapy 2009, 1, 49-62. [CrossRef] [PubMed]
152. Steinman, R.M. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 1991, 9, 271-296. [CrossRef] [PubMed]
153. Steinman, R.M. Dendritic cells and the control of immunity: Enhancing the efficiency of antigen presentation. Mt. Sinai J. Med. 2001, 68, 160-166. [PubMed]
154. Homma, S.; Matai, K.; Irie, M.; Ohno, T.; Kufe, D.; Toda, G. Immunotherapy using fusions of autologous dendritic cells and tumor cells showed effective clinical response in a patient with advanced gastric carcinoma. J. Gastroenterol. 2003, 38, 989-994. [CrossRef] [PubMed]
155. Kjaergaard, J.; Shimizu, K.; Shu, S. Electrofusion of syngeneic dendritic cells and tumor generates potent therapeutic vaccine. Cell. Immunol. 2003, 225, 65-74. [CrossRef] [PubMed]
156. Trevor, K.T.; Cover, C.; Ruiz, Y.W.; Akporiaye, E.T.; Hersh, E.M.; Landais, D.; Taylor, R.R.; King, A.D.; Walters, R.E. Generation of dendritic cell-tumor cell hybrids by electrofusion for clinical vaccine application. Cancer Immunol. Immunother. 2004, 53, 705-714. [CrossRef] [PubMed]
157. Scott-Taylor, T.H.; Pettengell, R.; Clarke, I.; Stuhler, G.; La Barthe, M.C.; Walden, P.; Dalgleish, A.G. Human tumour and dendritic cell hybrids generated by electrofusion: Potential for cancer vaccines. Biochim. Biophys. Acta 2000, 1500, 265-279. [CrossRef]
158. Hiraoka, K.; Yamamoto, S.; Otsuru, S.; Nakai, S.; Tamai, K.; Morishita, R.; Ogihara, T.; Kaneda, Y. Enhanced tumor-specific long-term immunity of hemagglutinating [correction of hemaggluttinating] virus of Japan-mediated dendritic cell-tumor fused cell vaccination by coadministration with CpG oligodeoxynucleotides. J. Immunol. 2004, 173, 4297-4307. [CrossRef] [PubMed]
159. Phan, V.; Errington, F.; Cheong, S.C.; Kottke, T.; Gough, M.; Altmann, S.; Brandenburger, A.; Emery, S.; Strome, S.; Bateman, A.; et al. A new genetic method to generate and isolate small, short-lived but highly potent dendritic cell-tumor cell hybrid vaccines. Nat. Med. 2003, 9, 1215-1219. [CrossRef] [PubMed]